Uncertainties in model-based outcome predictions for treatment planning

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 5, 2001, Pages 1389-1399

  Deasy, Joseph O ^a,b   Chao, K S Clifford ^a   Markman, Jerry ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dose volume; Normal tissue complication probability; Tumor control probability; Xerostomia

Indexed keywords

DRUG DOSAGE; TISSUE; TUMORS;

TREATMENT PLANNING;

PATIENT TREATMENT;

ACCURACY; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HISTOGRAM; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; METHODOLOGY; PARAMETER; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE DISTRIBUTION; RANDOMIZATION; RELIABILITY; SALIVARY GLAND FUNCTION; TREATMENT OUTCOME; TREATMENT PLANNING; XEROSTOMIA;

HUMANS; NEOPLASMS; PROBABILITY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 0035576670     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02659-1     Document Type: Article

References (45)

1. Optimized radiation therapy based on radiobiological objectives
2. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
3. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
4. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma
5. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer
6. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
7. Dose, volume, and function relationships in parotid salivary glands following conformal, and intensity-modulated irradiation of head and neck cancer
8. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model
9. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms
10. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
11. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results
12. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma
13. The probability of controlling an inhomogeneously irradiated tumor
14. Complication probability as assessed from dose-volume histograms
15. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
16. Modeling of normal tissue response to radiation: The critical volume model
17. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
18. Clinical interpretation of dose-volume histograms: The basis for normal tissue preservation and tumor dose escalation
19. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data
20. Prediction of overall pulmonary function loss in relation to the 3D dose distribution for patients with breast cancer and malignant lymphoma
21. Calculation of the uncertainty in the dose delivered during radiation therapy
22. Computerized design of target margins for treatment uncertainties in conformal radiotherapy
23. Managing geometric uncertainty in conformal intensity-modulated radiation therapy
24. An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion
25. A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities
26. Normal tissue complication probabilities: Dependence on choice of biological model and dose-volume histogram reduction scheme
27. The development and application of integrated procedures for post-closure assessment, based upon Monte Carlo simulation: The probabilistic systems assessment (PSA) approach
28. Prediction of radiotherapy response using SF2: Why it may work after all
29. Optimum parameters in a model for tumour control probability including inter-patient heterogeneity
30. A generalized concept of equivalent uniform dose (EUD)
31. Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation
32. Elementary analytical methods
33. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
34. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
35. Multi-institutional clinical trials. 3-D conformal radiotherapy quality assurance: Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy
36. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials: A brief report
37. Tumor control probability models for nonuniform dose distributions
38. Tumour and normal tissue responses to fractionated non-uniform dose delivery
39. Reporting and analyzing dose distributions: A concept of equivalent uniform dose